| Ytd | 5.73% | |
| 1y | -32.72% |
| Open | 0.74 | Prev Close | 0.76 | Low | 0.64 | High | 0.76 | Mkt Cap | 30.23M |
| Vol | 376.15K | Avg Vol | 50.54K | EPS | -1.02 | P/E | N/A | Forward P/E | -0.62 |
| Beta | -0.58 | Short Ratio | 0.19 | Inst. Own | 46.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 0.64 | 200-d Avg | 0.66 | 1yr Est | 7.25 |
BRNS News
Here is how Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) and Agilent Technologies (A) have per
Scheme Exchange Ratio determined at 0.111 pursuant to the terms of the merger agreement Scheme of ar
Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) progressing towards closing Comple
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“B
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ: BRNS - Get Free Report) saw a large increase in
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) might move higher on growing optimism about its e
Oncobiologics (NASDAQ: OTLK - Get Free Report) and Barinthus Biotherapeutics (NASDAQ: BRNS - Get Fre
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
SAN DIEGO , Oct. 24, 2025 /PRNewswire/ -- ChemDiv, a global provider of integrated drug discovery so
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
GERMANTOWN, MD and ALTRINCHAM, UK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- GERMANTOWN, MD and ALTRINCHAM,
OXFORD, GB AND GERMANTOWN, MD / ACCESS Newswire / June 9, 2025 / Barinthus Biotherapeutics plc annou
OXFORD, United Kingdom and GERMANTOWN, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Barinthus Biotherapeu
NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Bill Enright, CEO and Gemma Brown, CFO of Barinthus